Sort by

Send to

Choose Destination

Links from PubMed

Items: 14


Postprandial Hypertriglyceridemia Predicts Development of Insulin Resistance Glucose Intolerance and Type 2 Diabetes.

Aslam M, Aggarwal S, Sharma KK, Galav V, Madhu SV.

PLoS One. 2016 Jan 25;11(1):e0145730. doi: 10.1371/journal.pone.0145730.


Association Between IL-10 Gene Polymorphism and Diabetic Retinopathy.

Dong H, Li Q, Wang M, Wan G.

Med Sci Monit. 2015 Oct 22;21:3203-8.


Sulfonylureas and their use in clinical practice.

Sola D, Rossi L, Schianca GP, Maffioli P, Bigliocca M, Mella R, Corlianò F, Fra GP, Bartoli E, Derosa G.

Arch Med Sci. 2015 Aug 12;11(4):840-8. doi: 10.5114/aoms.2015.53304.


Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk.

Zou C, Hu H.

Vasc Health Risk Manag. 2013;9:429-33. doi: 10.2147/VHRM.S34421. Review.


Novel Role of Soluble Epoxide Hydrolase in Regulating Cholesterol in Mammalian Cells.

Enayetallah A, Cao L, Grant DF.

Open Drug Metab J. 2007 Jan 1;1:1-6.


The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats.

Stunes AK, Westbroek I, Gustafsson BI, Fossmark R, Waarsing JH, Eriksen EF, Petzold C, Reseland JE, Syversen U.

BMC Endocr Disord. 2011 May 26;11:11. doi: 10.1186/1472-6823-11-11.


Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study.

Rodríguez A, Reviriego J, Karamanos V, del Cañizo FJ, Vlachogiannis N, Drossinos V; ECLA Study Group..

Cardiovasc Diabetol. 2011 Feb 11;10:18. doi: 10.1186/1475-2840-10-18.


Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes.

Jonker JT, Wang Y, de Haan W, Diamant M, Rijzewijk LJ, van der Meer RW, Lamb HJ, Tamsma JT, de Roos A, Romijn JA, Rensen PC, Smit JW.

Diabetes Care. 2010 Jul;33(7):1625-8. doi: 10.2337/dc09-1935.


Thiazolidinediones as therapy for endometriosis: a case series.

Moravek MB, Ward EA, Lebovic DI.

Gynecol Obstet Invest. 2009;68(3):167-70. doi: 10.1159/000230713.


Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase.

EnayetAllah AE, Luria A, Luo B, Tsai HJ, Sura P, Hammock BD, Grant DF.

J Biol Chem. 2008 Dec 26;283(52):36592-8. doi: 10.1074/jbc.M806315200.


A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

Dorkhan M, Frid A.

Vasc Health Risk Manag. 2007;3(5):721-31. Review.


Metabolic effects of a conversion from rosiglitazone to pioglitazone in Native American patients with type 2 diabetes.

Sparkman J, Stroup J, Schupbach R, Carnahan R.

Proc (Bayl Univ Med Cent). 2007 Oct;20(4):349-53.

Items per page

Supplemental Content

Support Center